Immunicum AB(DE:1YG0)
€0.42-0.01 (-2.09%)
DE:1YG0
Immunicum AB financials statements
€0.42
At close:-0.01 (-2.09%)
Immunicum AB (1YG0) Financial Statements
1 Followers
Immunicum AB Financial Overview
Immunicum AB's market cap is currently kr28.04M. The company's EPS TTM is kr-1.79; its P/E ratio is -2.51; Immunicum AB is estimated to report earnings on February 11, 2027, and the estimated EPS forecast is kr-0.04. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 0.00 | kr 0.00 | kr 28.49M | kr 3.00M | kr 6.00K |
| Gross Profit | kr -6.29M | kr -6.52M | kr 28.49M | kr -1.85M | kr -1.84M |
| Operating Income | kr -120.26M | kr -135.15M | kr -100.65M | kr -133.68M | kr -130.10M |
| EBITDA | kr -113.97M | kr -120.68M | kr -94.92M | kr -128.67M | kr -128.28M |
| Net Income | kr -113.26M | kr -128.40M | kr -101.62M | kr -136.99M | kr -136.69M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 64.66M | kr 101.91M | kr 120.78M | kr 41.85M | kr 155.31M |
| Total Assets | kr 628.32M | kr 696.36M | kr 755.95M | kr 620.39M | kr 720.98M |
| Total Debt | kr 18.85M | kr 22.71M | kr 24.49M | kr 78.16M | kr 36.98M |
| Net Debt | kr -45.81M | kr -79.20M | kr -96.29M | kr 36.31M | kr -118.34M |
| Total Liabilities | kr 43.26M | kr 51.22M | kr 51.23M | kr 105.95M | kr 64.24M |
| Stockholders' Equity | kr 585.07M | kr 645.15M | kr 704.73M | kr 514.44M | kr 656.74M |
| Cash Flow | |||||
| Free Cash Flow | kr -81.84M | kr -81.51M | kr -164.58M | kr -121.43M | kr -139.39M |
| Operating Cash Flow | kr -81.53M | kr -79.67M | kr -162.76M | kr -109.33M | kr -138.03M |
| Investing Cash Flow | kr -734.00K | kr -1.58M | kr -442.00K | kr -12.32M | kr -1.36M |
| Financing Cash Flow | kr 45.18M | kr 61.52M | kr 242.10M | kr 8.19M | kr 127.03M |
Currency in SEK
